相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Blockade of miR-3614 maturation by IGF2BP3 increases TRIM25 expression and promotes breast cancer cell proliferation
Zhenzhen Wang et al.
EBIOMEDICINE (2019)
The impact of phosphatases on proliferative and survival signaling in cancer
Goutham Narla et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2018)
The E3 ligase for metastasis associated 1 protein, TRIM25, is targeted by microRNA-873 in hepatocellular carcinoma
Yu-Hui Li et al.
EXPERIMENTAL CELL RESEARCH (2018)
Efficacy and safety of epirubicin applied in transcatheter arterial chemoembolization for hepatocellular carcinoma: A meta-analysis
Zhibin Bai et al.
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS (2018)
TRIM25 enhances cell growth and cell survival by modulating p53 signals via interaction with G3BP2 in prostate cancer
Ken-ichi Takayama et al.
ONCOGENE (2018)
Oncogenic TRIM31 confers gemcitabine resistance in pancreatic cancer via activating the NF-κB signaling pathway
Chao Yu et al.
THERANOSTICS (2018)
TRIM32 promotes proliferation and confers chemoresistance to breast cancer cells through activation of the NF-kappa B pathway
Ting-Ting Zhao et al.
JOURNAL OF CANCER (2018)
The E3 ubiquitin ligase TRIM25 regulates adipocyte differentiation via proteasome-mediated degradation of PPARγ
Jae Min Lee et al.
EXPERIMENTAL AND MOLECULAR MEDICINE (2018)
The ubiquitin ligase TRIM25 inhibits hepatocellular carcinoma progression by targeting metastasis associated 1 protein
Hong-liang Zang et al.
IUBMB LIFE (2017)
Nanomedicine to Deal With Cancer Cell Biology in Multi-Drug Resistance
Pawan Tekchandani et al.
MINI-REVIEWS IN MEDICINAL CHEMISTRY (2017)
TRIM59 facilitates the proliferation of colorectal cancer and promotes metastasis via the PI3K/AKT pathway
Ye Sun et al.
ONCOLOGY REPORTS (2017)
TRIM Family Proteins: Roles in Autophagy, Immunity, and Carcinogenesis
Shigetsugu Hatakeyama
TRENDS IN BIOCHEMICAL SCIENCES (2017)
miR-182 promotes tumor growth and increases chemoresistance of human anaplastic thyroid cancer by targeting tripartite motif 8
Yao Liu et al.
OncoTargets and Therapy (2017)
An Integrated Systems Biology Approach Identifies TRIM25 as a Key Determinant of Breast Cancer Metastasis
Logan A. Walsh et al.
CELL REPORTS (2017)
UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
Darshan S. Chandrashekar et al.
NEOPLASIA (2017)
TRIM14 regulates cell proliferation and invasion in osteosarcoma via promotion of the AKT signaling pathway
Guoxing Xu et al.
SCIENTIFIC REPORTS (2017)
HSF1 upregulates ATG4B expression and enhances epirubicin-induced protective autophagy in hepatocellular carcinoma cells
Nan Zhang et al.
CANCER LETTERS (2017)
TRIM25 is associated with cisplatin resistance in non-small-cell lung carcinoma A549 cell line via downregulation of 14-3-3σ
Xia Qin et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2017)
Overexpression of TRIM25 in Lung Cancer Regulates Tumor Cell Progression
Ying Qin et al.
TECHNOLOGY IN CANCER RESEARCH & TREATMENT (2016)
被撤回的出版物: TRIM25 blockade by RNA interference inhibited migration and invasion of gastric cancer cells through TGF-β signaling (Retracted article. See vol. 13, 2023)
Zhenya Zhu et al.
SCIENTIFIC REPORTS (2016)
The BCL-2 protein family, BH3-mimetics and cancer therapy
A. R. D. Delbridge et al.
CELL DEATH AND DIFFERENTIATION (2015)
HES5 promotes cell proliferation and invasion through activation of STAT3 and predicts poor survival in hepatocellular carcinoma
Guizhou Zhu et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2015)
TRIM24 promotes glioma progression and enhances chemoresistance through activation of the PI3K/Akt signaling pathway
L-H Zhang et al.
ONCOGENE (2015)
Treatment of intermediate-stage hepatocellular carcinoma
Alejandro Fomer et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Targeting the Akt Kinase to Modulate Survival, Invasiveness and Drug Resistance of Cancer Cells
Giuliana Cassinelli et al.
CURRENT MEDICINAL CHEMISTRY (2013)
Doxorubicin: an update on anticancer molecular action, toxicity and novel drug delivery systems
Oktay Tacar et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2013)
p53-Independent up-regulation of a TRAIL receptor DR5 by proteasome inhibitors: A mechanism for proteasome inhibitor-enhanced TRAIL-induced apoptosis
Dai-Wu Seol
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Lupeol Targets Liver Tumor-Initiating Cells Through Phosphatase and Tensin Homolog Modulation
Terence Kin Wah Lee et al.
HEPATOLOGY (2011)
Chemotherapy for advanced hepatocellular carcinoma
Kwang-Hyub Han et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2008)
MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer
Fanyin Meng et al.
GASTROENTEROLOGY (2007)
TRIM25 RING-finger E3 ubiquitin ligase is essential for RIG-I-mediated antiviral activity
Michaela U. Gack et al.
NATURE (2007)
LY294,002, a specific inhibitor of PI3K/Akt kinase pathway, antagonizes P-glycoprotein-mediated multidrug resistance
Miroslav Barancik et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2006)
The PI3K inhibitor LY294002 blocks drug export from resistant colon carcinoma cells overexpressing MRP1
R Abdul-Ghani et al.
ONCOGENE (2006)
Increasing 14-3-3 sigma expression with declining estrogen receptor α and estrogen-responsive finger protein expression defines malignant progression of endometrial carcinoma
H Nakayama et al.
PATHOLOGY INTERNATIONAL (2005)
Expression and prognostic role of tumor suppressor gene PTEN/MMAC1/TEP1 in hepatocellular carcinoma
TH Hu et al.
CANCER (2003)
Efp targets 14-3-3σ for proteolysis and promotes breast tumour growth
T Urano et al.
NATURE (2002)
分享论文
